Background: The presence of tumor-infiltrating lymphocytes (TILs) is associated
| INTRODUCTION
The oral cavity is a distinct site in the head and neck region, and oral cavity cancers account for 3% of all cancers. Oral cancer is a minor subset of head and neck cancer and is drastically different in etiology, management and prognosis from other head and neck cancers. For instance, oral squamous cell carcinoma (OSCC) is associated with distinct clinical characteristics showing unfavorable prognosis compared to human papilloma virus-positive oropharyngeal cancer. 1 Tumor-infiltrating lymphocytes (TILs) have been described as a prognostic factor in various types of cancers. [2] [3] [4] In head and neck squamous cell carcinoma (HNSCC), the presence of TILs indicates a favorable prognosis, 5 and TILs at periphery of the tumor is a positive prognostic marker for patients with OSCC. 6 Functional analysis of TILs in rats showed that T-cells infiltrating in the tumor tissues have effects on tumor rejection, 7 suggesting the presence of host antitumor immunological resistance and a key role for cell-mediated immunity in tumor immunology. Additionally, the immune infiltrate of human tumors is mainly composed of lymphocytes, with T cells being the predominant cell type. [8] [9] [10] Therefore, the immune system plays a key role in the control of tumor growth and progression. 11 Moreover, an abundance of T-cell infiltrates is associated with favorable clinical outcome in many types of cancers, including head and neck cancer, 12 and the exclusion of CD8 + T cells from the vicinity of cancer cells in colorectal tumors correlates with a poor longterm clinical outcome. 13 Patients with HNSCC with high tumor infiltration of CD8 + T cells have significantly better outcomes compared to those with lower or no infiltration.
14 Few studies, however, have examined the predictive impact of CD8 + T-cell infiltration in OSCC. It has been reported that a high TIL density is significantly associated with favorable prognosis, although the prognostic value of tumor-infiltrating CD8 + T cells remains controversial. 15, 16 The location of predictive immune cell infiltrates in various tissue compartments remains unclear, and tumor-infiltrating immune cell infiltrate is not homogeneous in OSCC. Oguejiofor et al 17 showed on multivariate analysis that a high density of CD8 + T cells in the tumor stroma, but not the tumor parenchyma, was associated with significantly better overall survival (OS) in human papilloma virus-positive oropharyngeal SCC, whereas Nguyen et al 18 B, IHC), the parenchyma and stroma in the invading tumor edge (C, H&E; D, IHC), and the periphery of the tumor (E, H&E; F, IHC; G, H&E; H, IHC). The invading edge is a belt zone including a tumor nest layer inside the tumor border. The periphery of the tumor is outside of the tumor border. Evaluation of peripheral CD8 + T-cell density included the area of most scattered cancer cells or small islands (G and H rather than E and F).
The regions in the rectangle (A, C, E, and G) are shown at ×100 magnification of the arrowed panel invasive tumor edge is the first line of defense against cancer proliferation and metastasis, these observations have led to the hypothesis that direct and indirect effector CD8 + T cells infiltrate the parenchyma or stroma of different anatomical areas, such as the center of the tumor, invading tumor edge, or tumor periphery. The aim of this study was to conduct immunohistochemical evaluation of the density and location of five types of CD8 + cytotoxic T-cell infiltrates, including those located in stroma in the center of the tumor, parenchyma in the center of the tumor, stroma in the invading tumor edge, parenchyma in the invading tumor edge, and periphery of the tumor, to investigate their prognostic relevance in OSCC. 
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| PATIENTS AND METHODS
| Patients and tissue samples
| Histopathological and immunohistopathological evaluations
As the ultimate interest of this study was to analyze cytotoxic CD8 + T cells together, distinguished based on their five different locations, CD8 + T cells were evaluated in the following five different areas of the tumor: the tumor parenchyma (within the cancer cell nests) and tumor stroma at the intratumoral center and invading tumor edge (inside of the tumorhost interface), and the periphery of the tumor ( Figure 1 ). CD8 + T-cell density was quantitatively assessed. After the CD8 + T cells were identified in the five locations at low magnification, they were counted manually in the areas of highest CD8 + intensity under 400x magnification, and cell counts were averaged. Tumor areas with crush artifacts, necrosis, or apoptosis were excluded from analysis. The CD8 + T cells at the invading tumor edge were estimated from small clusters of forming cancer cells or nests at deepest invading margin. For assessment of tumor-infiltrating CD8 + T-cell density in each compartment, at least three random fields were viewed, and, in cases of heterogeneity, the calculation that was most representative of the entire section was assigned. The analysis of CD8 + T cell density was assessed using DP2-BSW software for an Olympus Microscope Digital Camera (Olympus Co., Tokyo, Japan) by three of the authors (SS, KK, and AM) simultaneously. The mean T-cell density for each compartment was used to stratify patients into high and low CD8 + T-cell density groups. The prognostic role of CD8 + T-cell density was analyzed for each of the five different tumor areas. During the assessment of tumor-infiltrating CD8 + T-cell density, the labels bearing the patient's names were covered. The relationships between CD8 + T-cell density and clinicopathological findings were also examined. Histopathologic findings were tabulated from information in routine histopathologic reports. The tumor extent and the histopathological grading were classified according to the 7th version of the American Joint Committee on Cancer TNM staging system. 20 
| Statistical analysis
For nonparametric distribution of samples, P-values were calculated by the Wilcoxon-Mann-Whitney test. Associations between the density of CD8 + T-cell infiltration and clinicopathological findings were evaluated using Fisher's exact test or chi-square test. Disease-specific survival (DSS) was calculated from the date of definitive surgery to death with the tumor. OS was defined from the date of definitive surgery to death from any cause. Recurrence-free survival (RFS) was defined from the date of definitive surgery to locoregional or distant tumor recurrence or death from any cause. DSS, OS, and RFS were calculated using the Kaplan-Meier method and compared using the log-rank test for each group. 3 | RESULTS
| Patient and tumor characteristics
Between January 2004 and December 2014, a total of 221 primary patients were treated by curative surgery. Of these, 139 patients were treated without neoadjuvant therapy and had sufficient tissue sample for further analysis. The mean age of the patients at diagnosis was 67 years (range Table 1 ). The density of the tumor-infiltrating CD8 + T cells was significantly associated with location in the tumor (Figure 2 ), suggesting that the number of CD8 + T cells significantly number of CD8 + T cells significantly increased in the invading edge and periphery of the tumor as compared to the center of the tumor, in both the stroma and parenchyma (P < 0.01 and P < 0.01, respectively). Based on the results, the host reaction was investigated by using mean cutoff values for each compartment. Figure 3 illustrates the representative examples of low and high parenchymal and stromal CD8 + T-cell infiltration.
| CD8 + T-cell density and survival
The median follow-up period for all patients was 79 months (range 4-164 months). The primary tumor recurred in 16 patients (11.5%), and regional lymph node relapse was found in 25 patients (18.0%). The 5-year DSS, OS, and RFS of all patients were 89.6%, 82.4%, and 62.2%, respectively. Patients with OSCC with high CD8 + T-cell density in the parenchymal invading tumor edge had a significantly superior DSS (100% vs 83.6%, P < 0.01) and OS (93.6% vs 76.1%, P < 0.01), whereas high CD8 + T-cell density in the parenchyma at the center of the tumor was not associated with improved DSS or OS in univariate analysis (Table 2) . Patients with OSCC with high CD8 + T-cell density only in the periphery of the tumor had a significantly superior RFS (77.1% vs 55.1%, P < 0.01). CD8 + T-cell density in any other compartment was not associated with RFS, DSS, or OS in univariate analysis ( Figure  4 ). Thus, high stromal CD8 + T-cell infiltration in the periphery of the tumor and parenchyma in the invading tumor edge were significantly associated with DSS, OS, and RFS, whereas high stromal CD8 + T-cell infiltration at other sites was not. Similarly, high parenchymal CD8 + T-cell infiltration in the tumor invading edge also significantly affected DSS and OS, whereas high parenchymal CD8 + T-cell infiltration in the center of the tumor did not ( Table 2) . The relationships between survival and traditional prognostic factors were also examined. As expected, age (P < 0.01), tumor site (P = 0.01), cT stage (P = 0.01), cN stage (P < 0.01), cTNM stage (P = 0.01), operative method (P < 0.01), pT stage (P < 0.01), pN stage (P < 0.01), pTNM stage (P < 0.01), and presence of perineural invasion (P < 0.01) were associated with DSS in univariate analyses. Age (P < 0.01), tumor site (P < 0.01), cT stage (P < 0.01), cN stage (P < 0.01), cTNM stage (P < 0.01), operative method (P < 0.01), pT stage (P < 0.01), pN stage (P < 0.01), pTNM stage (P < 0.01), and presence of perineural invasion (P < 0.01) were also associated with OS. Similarly, age (P = 0.02), histological tumor grade (P < 0.01), pT stage (P = 0.01), pN stage (P < 0.01), pTNM stage (P < 0.01), presence of lymphovascular invasion (P = 0.03), and presence of perineural invasion (P < 0.01) were also associated with RFS. 
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were significantly associated with OS and DSS. OSCC of tongue and floor of the mouth were also significantly associated with tumor-related and tumor-unrelated death ( A recent meta-analysis on tumor-infiltrating immune cells suggested that the amount and density of tumor-infiltrating CD8 + T cell also affected survival in HNSCC patients, 30 whereas there is controversy as to whether higher levels of tumor-infiltrating CD8 + T cells improve survival in patients with OSCC. Several studies indicated that tumor-infiltrating immune cells did not provide any survival benefit in patients with OSCC. 31, 32 However, these observations were made in a small sample size (under 50 subjects) and a shorter follow-up duration than used with the present cohort. Those studies also examined different tumor areas. Some authors have indicated that immune cells infiltration affected OS, DSS, and DFS. 15, 19, 33 Higher CD4 + cell levels was an independent predictor for improved OS and DSS in 278 patients with HNSCC who received heterogeneous treatment strategies. 18 In contrast, Balermpas et al, 19 showed that high CD3 + and CD8 + T-cell density were associated with significantly increased OS and PFS in patients receiving definitive chemoradiotherapy, while neither CD4 + nor FoxP3 + immune cell density showed significance for the clinical outcome. The authors of the present study have previously reported that high stromal T-cell density increases the effectiveness of neoadjuvant bleomycin therapy in patients with OSCC. 9 Differences in tumor-infiltrating T-cell subsets could influence the effectiveness of cancer treatment. Recently, Tabachnyk et al, 16 showed that a high density of tumor-infiltrating CD8 + T cells observed in OSCC patients had a better DFS after concurrent chemoradiotherapy followed by surgery. Similar research data with respect to neoadjuvant therapy have been reported in breast cancer. 34 However, little is known whether adjuvant local and/or systemic cancer therapy could influence the outcomes of studies evaluating CD8 + T-cell infiltration or not. Patients with positive surgical margin in the present study did not receive routine adjuvant therapy. The present study considered relationships between localization, density of CD8 + T-cell infiltration, clinicopathological parameters, outcome, and prognosis. The relationships between the locations of CD8 + T-cell infiltrates, CD8 + T-cell density, and survival are diverse. Naito et al 13 showed that marked stromal infiltration of CD8 + T cells at the advancing tumor margin was an independent prognostic factor for a longer DFS in colorectal cancer. Bindea et al 36 reported that higher CD8 + T-cell density was observed in the stroma than in the parenchyma. They also showed that stromal CD8 + T-cell density was higher in the invasive margin than in the center of the tumor, whereas parenchymal and stromal CD8 + T-cell density showed approximately equal densities. Furthermore, their study demonstrated that parenchymal CD8 + T-cell density was significantly associated with a better RFS in colorectal cancer. In OSCC, as shown in the current study, stromal CD8 + T-cell density was higher than parenchymal CD8 + T-cell density in the center of the tumor, as well as in the invading edge. The specific locations of adaptive cellular immune reaction within tumor samples, especially within the core of the tumor and the invasive margin, are highly significant parameters to predict tumor relapse and survival. Galon The tumor microenvironment may regulate the accumulation of T cells in tumors at the initial step of their interaction with local blood vessels. 39 The presence of tumor-infiltrating CD8 + T cells can predict the response of solid tumors to anti-PD-1 monoclonal antibody therapy. 42 Moreover, clinical and histopathological anticancer effects of chemotherapy and/or concomitant chemoradiotherapy may depend on vascularity in the tumor microenvironment. 43 Therefore, assessment of CD8 + T-cell density in specific locations in biopsied samples can be used as a novel tool for selecting responders to these treatment strategies. In addition, as described by Bindea et al, 36 In summary, the results of this study showed significant associations between increased tumor-infiltrating CD8 + T cells and their tissue localization in OSCC. High stromal CD8 + T-cell density at the periphery of the tumor and high parenchymal CD8 + T-cell density at the invading edge were independent prognostic makers for RFS and OS, respectively. Thus, the present study revealed site-specific informative features of the CD8 + T-cell infiltration: the parenchyma at invading tumor edge and the peritumor. Pathological immunity evaluation may provide crucial novel prognostic information and help identify patient cohorts likely to benefit from immunotherapy.
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